AXL and neoplasm: Intriguingly, bemcentinib did not appear to uniformly affect the EMT program in this condition, suggesting that the observed immune sensitization of tumor cells relied on alterations in AXL signaling, rather than solely on alterations of the mesenchymal phenotype in this model.